Degenerative, calcific valvular aortic stenosis (AS), caused by an active process of
atherosclerosis, calcification and ossification, is the most common cause of AS in …

In the 16 years since the first pioneering procedure, transcatheter aortic valve implantation
(TAVI) has come of age and become a routine strategy for aortic valve replacement …

Aims The number of transcatheter aortic valve implantation (TAVI) procedures is rapidly
increasing. This has a major impact on health care resource planning. However, the annual …

Objectives: The purpose of this study was to evaluate the prevalence of aortic stenosis (AS)
in the elderly and to estimate the current and future number of candidates for transcatheter …

Importance Introducing new medical devices into routine practice raises concerns because
patients and outcomes may differ from those in randomized trials. Objective To update the …

Background: Limited information exists describing the results of transcatheter aortic valve
(TAV) replacement in patients with bicuspid aortic valve (BAV) disease (TAV-in-BAV) …

Aims A comprehensive description of transcatheter heart valve (THV) failure has not been
performed. We undertook a systematic review to investigate the aetiology, diagnosis …

Background: There is a paucity of prospective and controlled data on the comparative
effectiveness of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve …

De Backer et al Transcatheter Mitral Valve Replacement 401 increase overall efficacy. 11
However, for many patients MV repair will not be possible, and MV replacement will be …

Since the introduction of transcatheter aortic valve implantation (TAVI) into clinical practice,
the treatment of aortic stenosis has changed dramatically. In the past, medical therapy with …